Cargando…

Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a common malignancy with dismal prognosis. Metastatic spread and therapeutic resistance, the main causes of PDAC-related mortalities, are both partially underlined by the epithelial-mesenchymal transition (EMT) of PDAC cells. While the role of W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Menghan, Quek, Lake-Ee, Sultani, Ghazal, Turner, Nigel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066287/ https://www.ncbi.nlm.nih.gov/pubmed/27777765 http://dx.doi.org/10.1186/s40170-016-0160-x

Ejemplares similares

Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells
por: Liu, Menghan, et al.
Publicado: (2019)

Fast exchange fluxes around the pyruvate node: a leaky cell model to explain the gain and loss of unlabelled and labelled metabolites in a tracer experiment
por: Quek, Lake-Ee, et al.
Publicado: (2016)

Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
por: Hu, Xiu, et al.
Publicado: (2021)

Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
por: Xiao, Yuanyuan, et al.
Publicado: (2017)

Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma
por: Porter, Rebecca L., et al.
Publicado: (2019)

The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion
por: Yang, Jian, et al.
Publicado: (2023)

CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
por: Steele, Colin W., et al.
Publicado: (2016)

Epithelial to Mesenchymal Transition: Key Regulator of Pancreatic Ductal Adenocarcinoma Progression and Chemoresistance
por: Palamaris, Kostas, et al.
Publicado: (2021)

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma
por: Liu, Yu-Huei, et al.
Publicado: (2022)

Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
por: Liu, Zhao, et al.
Publicado: (2023)

Role of Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Is Tumor Budding the Missing Link?
por: Karamitopoulou, Eva
Publicado: (2013)

Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
por: Dhayat, Sameer Abdallah, et al.
Publicado: (2018)

Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents
por: Khalafalla, Farid G, et al.
Publicado: (2017)

Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities
por: Dardare, Julie, et al.
Publicado: (2021)

Glutamine addiction promotes glucose oxidation in triple-negative breast cancer
por: Quek, Lake-Ee, et al.
Publicado: (2022)

Tumor-associated macrophages promote pancreatic ductal adenocarcinoma progression by inducing epithelial-to-mesenchymal transition
por: Xiong, Cheng, et al.
Publicado: (2021)

The Role of SMAD4 Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
por: Racu, Marie-Lucie, et al.
Publicado: (2022)

Epithelial and Mesenchymal Features of Pancreatic Ductal Adenocarcinoma Cell Lines in Two- and Three-Dimensional Cultures
por: Shichi, Yuuki, et al.
Publicado: (2022)

DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy
por: Dardare, Julie, et al.
Publicado: (2022)

A depth-first search algorithm to compute elementary flux modes by linear programming
por: Quek, Lake-Ee, et al.
Publicado: (2014)

Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma
por: Hadi, Marym Mohammad, et al.
Publicado: (2022)

Connexin-43 channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells
por: Dovmark, T H, et al.
Publicado: (2017)

Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes
por: Huang, Xin, et al.
Publicado: (2023)

Laminin-332 mediates proliferation, apoptosis, invasion, migration and epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma
por: Huang, Caiqun, et al.
Publicado: (2021)

Oxysterol-Binding Protein 2 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Epithelial-Mesenchymal Transition
por: Huang, Shuai, et al.
Publicado: (2022)

Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma
por: Ji, Fei, et al.
Publicado: (2016)

Irreversible electroporation augments β-glucan induced trained innate immunity for the treatment of pancreatic ductal adenocarcinoma
por: Woeste, Matthew R, et al.
Publicado: (2023)

Correction to: Nanotechnology-augmented sonodynamic therapy and associated immune-mediated effects for the treatment of pancreatic ductal adenocarcinoma
por: Hadi, Marym Mohammad, et al.
Publicado: (2023)

Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release
por: Morioka, Sho, et al.
Publicado: (2018)

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
por: Acuna-Villaorduna, Ana, et al.
Publicado: (2022)

Inhibition of DCLK1 kinase reverses epithelial-mesenchymal transition and restores T-cell activity in pancreatic ductal adenocarcinoma
por: Ge, Yang, et al.
Publicado: (2022)

Notch signaling regulates vasculogenic mimicry and promotes cell morphogenesis and the epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma
por: Benjakul, Nontawat, et al.
Publicado: (2022)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Epithelial-to-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma and Pancreatic Tumor Cell Lines: The Role of Neutrophils and Neutrophil-Derived Elastase
por: Große-Steffen, Thomas, et al.
Publicado: (2012)

Upregulation of nucleoprotein AHNAK is associated with poor outcome of pancreatic ductal adenocarcinoma prognosis via mediating epithelial-mesenchymal transition
por: Zhang, Zhiwen, et al.
Publicado: (2019)

High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma
por: Sánchez-Ramírez, Damián, et al.
Publicado: (2022)

Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma
por: Lee, Lucas D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4scms62uiumliklmrtl8n8fph8